STRATA Skin Sciences Inc (SSKN) - Total Assets
Based on the latest financial reports, STRATA Skin Sciences Inc (SSKN) holds total assets worth $30.52 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
STRATA Skin Sciences Inc - Total Assets Trend (2000–2025)
This chart illustrates how STRATA Skin Sciences Inc's total assets have evolved over time, based on quarterly financial data. Also see how much is STRATA Skin Sciences Inc worth for the company's overall valuation and market capitalisation.
STRATA Skin Sciences Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
STRATA Skin Sciences Inc's total assets of $30.52 Million consist of 51.1% current assets and 48.9% non-current assets. Review STRATA Skin Sciences Inc (SSKN) total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 25.9% |
| Accounts Receivable | $4.12 Million | 13.5% |
| Inventory | $2.81 Million | 9.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $3.38 Million | 11.1% |
| Goodwill | $1.43 Million | 4.7% |
Asset Composition Trend (2000–2025)
This chart illustrates how STRATA Skin Sciences Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for STRATA Skin Sciences Inc for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: STRATA Skin Sciences Inc's current assets represent 51.1% of total assets in 2025, a decrease from 92.1% in 2000.
- Cash Position: Cash and equivalents constituted 25.9% of total assets in 2025, up from 0.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 13.5% of total assets.
STRATA Skin Sciences Inc Competitors by Total Assets
Key competitors of STRATA Skin Sciences Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
LENSAR Inc
NASDAQ:LNSR
|
USA | $69.56 Million |
|
Lumos Diagnostics Holdings Ltd
AU:LDX
|
Australia | AU$21.12 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
STRATA Skin Sciences Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.58 | 1.13 | 1.20 |
| Quick Ratio | 0.48 | 0.98 | 1.03 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-11.14 Million | $1.97 Million | $4.00 Million |
STRATA Skin Sciences Inc - Advanced Valuation Insights
This section examines the relationship between STRATA Skin Sciences Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.26 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -15.6% |
| Total Assets | $30.52 Million |
| Market Capitalization | $29.44K USD |
Valuation Analysis
Below Book Valuation: The market values STRATA Skin Sciences Inc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: STRATA Skin Sciences Inc's assets decreased by 15.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for STRATA Skin Sciences Inc (2000–2025)
The table below shows the annual total assets of STRATA Skin Sciences Inc from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $30.52 Million | -15.59% |
| 2024-12-31 | $36.16 Million | -13.94% |
| 2023-12-31 | $42.02 Million | -19.62% |
| 2022-12-31 | $52.27 Million | +12.19% |
| 2021-12-31 | $46.59 Million | -0.40% |
| 2020-12-31 | $46.78 Million | -1.19% |
| 2019-12-31 | $47.34 Million | -0.35% |
| 2018-12-31 | $47.51 Million | +22.98% |
| 2017-12-31 | $38.63 Million | -10.56% |
| 2016-12-31 | $43.19 Million | -15.92% |
| 2015-12-31 | $51.37 Million | +155.96% |
| 2014-12-31 | $20.07 Million | +42.02% |
| 2013-12-31 | $14.13 Million | -18.17% |
| 2012-12-31 | $17.27 Million | -44.99% |
| 2011-12-31 | $31.39 Million | -6.54% |
| 2010-12-31 | $33.59 Million | +4.55% |
| 2009-12-31 | $32.13 Million | +93.31% |
| 2008-12-31 | $16.62 Million | -24.83% |
| 2007-12-31 | $22.11 Million | -1.64% |
| 2006-12-31 | $22.48 Million | +17.27% |
| 2005-12-31 | $19.17 Million | +170.09% |
| 2004-12-31 | $7.10 Million | +1542.63% |
| 2003-12-31 | $432.00K | +25.58% |
| 2002-12-31 | $344.00K | -69.58% |
| 2001-12-31 | $1.13 Million | -70.35% |
| 2000-12-31 | $3.81 Million | -- |
About STRATA Skin Sciences Inc
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer … Read more